✦ LIBER ✦

Patient and Institutional Predictors of Trimodality Therapy for Stage III Non-Small Cell Lung Cancer (NSCLC) in the National Cancer Database

✍ Scribed by Sher, D.J.; Liptay, M.J.; Fidler, M.J.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Association Between Trimodality Therapy

✍ Sher, D.J.; Fidler, M.J.; Liptay, M.J. 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 44 KB

Trimodality Therapy for Locally Advanced

✍ Liriano, M.; Nichols, E.M.; Morris, C.G.; Burrows, W.; Battafarano, R.J.; Garofa 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 71 KB

Prevalence and Predictors of Neoadjuvant

✍ Sher, David J.; Liptay, Michael J.; Fidler, Mary Jo 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 317 KB

The Effect of Pathological Response on S

✍ G.A. Neuner; N.A. VanderWalde; O. Goulobeva; M. Suntharalingam; R.J. Battafarano 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 55 KB

Results of Trimodality Therapy in Patien

✍ Jian Li; Chun-Hua Dai; Li-Chao Yu; Ping Chen; Xiao-Qin Li; Shun-Bing Shi; Jing-R 📂 Article 📅 2009 🏛 CIG Media Group, LP. 🌐 English ⚖ 119 KB

Comprehensive Analysis of Dosimetric Pre

✍ Speirs, C.K.; Rehman, S.; Molotievschi, A.; Velez, M.A.; DeWees, T.A.; Mullen, D 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 57 KB